期刊文献+

海藻酸钠/淀粉复合微球的制备及性能研究 被引量:3

Research on synthesis and performance of SA/ST microspheres
下载PDF
导出
摘要 以SA和ST为基质材料制备SA/ST复合微球,由单因素固定变量实验对SA/ST复合微球的合成进行研究,得到最佳实验条件为:总质量分数为6%,SA、ST质量比例为3:1。由红外光谱分析样品的化学结构,发现SA和ST之间通过氢键作用复合。研究结果表明,SA和ST总质量分数为6%时,微球有较高的包埋率和载药量,分别为65.00%和3.23%。载药微球在5~6h就可以达到完全释药,实验表明随着总质量分数增大微球的释药率降低。复合微球的溶血率为1.9%,小于国家标准5%,证明SA/ST复合微球有较好的血液相容性。 The SA/ST composite microspheres were synthesized with sodium alginate and starch. The syntheses of SA/ST microspheres were studied by experiment of fixing single factor. The results showed that excellent conditions of SA/ST microspheres were the total mass of 6%, the mass fraction of SA to ST of 3 : 1. SA and ST made interaction through hydrogen bond by FTIR. The result showed that when SA/ST total mass fraction of 6 %, microspheres had better encapsulation efficiency and drug loading rate,i, e. 65.00% and 3. 23% respectively. The drug-loaded microspheres could release completely in 5-6 hours. The result demonstrated that the drug releasing efficiency of microspheres decreased with the increasing of the total mass fraction. The hemolysis ratio was 1.9%,less than the national standard of 5 %. It indicated that SA/ST mierospheres were hemocompatible.
出处 《化工新型材料》 CAS CSCD 北大核心 2013年第11期44-46,共3页 New Chemical Materials
基金 国家自然科学基金资助项目(51003088 50573061) 中央高校基本科研业务费专项资金资助(2010ZT09 SWJTU12CX047 SWJTU12CX048)
关键词 海藻酸钠 可溶性淀粉 微球 sodium alginate, soluble starch, microsphere
  • 相关文献

参考文献1

二级参考文献6

  • 1Ispas-Szabo.P,Ravenelle.F Structure-properties relationship in cross-linked high-amylose starch for use in controlled drug release.Carbohydrate Research,1999; (323):163-175.
  • 2Te Wierik G,Henk P,Eissens,Anko C,et al.A new generation of starch products as excipient in pharmaceutical tablets.II.High surface area retrograded pregelatinized potato starch products in sustained-release tablets.Journal of control.Release.1997,(45):25-33.
  • 3Clausen AE,Bemkop-Schnurch A.Direct compressible polymethacrylic acid-starch compositions for site-specific drug delivery.Journal of Controlled Release.2001; (75):91-102.
  • 4Russell GFJ.Starch microspheres as drug delivery system.Pharmacy International.1983; (10):260.
  • 5Lindberg B,Lote K,Teder H,et al.Microspheres and drug therapy pharmaceutical immunological and medical aspects 1984.Elsevier Science Publishers BU.1984:153.
  • 6肖光渭.临床运用淀粉和糖类物质的思考[J].江西中医学院学报,2000,12(2):66-67. 被引量:3

共引文献9

同被引文献20

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部